Anupama Betkerur Horne, MD | |
6104 Fayetteville Rd, Suite 108, Durham, NC 27713-6283 | |
(919) 572-0050 | |
(919) 572-9200 |
Full Name | Anupama Betkerur Horne |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 19 Years |
Location | 6104 Fayetteville Rd, Durham, North Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013098946 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 2009-01149 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Duke University Hospital | Durham, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Duke Health Integrated Practice Inc | 8325412737 | 2551 |
News Archive
Integra LifeSciences Holdings Corporation announced today that the results of the multi-center human clinical trial comparing NeuraGen Nerve Guide with direct suture repair have been accepted, in abstract form, for presentation at the joint meeting of the American Association for Hand Surgery (AAHS), American Society for Reconstructive Microsurgery (ASRM), and American Society for Peripheral Nerve (ASPN), January 12-18, 2011, Cancun Mexico.
The spiraling use of corn for food and fuel is creating heightened concerns about contamination of this staple crop with deadly aflatoxin.
Savient Pharmaceuticals, Inc. announced that its board of directors, with input from its financial advisors, has determined that a sale of Savient post-approval of KRYSTEXXA by the U.S. Food and Drug Administration (assuming KRYSTEXXA is approved) would be the best way to realize the full commercial potential of KRYSTEXXA on a global basis and would be the optimal outcome for the Company's shareholders and other stakeholders.
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from three studies using the company's breast cancer molecular test.
Delayed transfer to the intensive care unit (ICU) in hospitalized patients significantly increases the risk of dying in the hospital, according to a new study from researchers in Chicago.
› Verified 5 days ago
Entity Name | Private Diagnostic Clinic Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
Integra LifeSciences Holdings Corporation announced today that the results of the multi-center human clinical trial comparing NeuraGen Nerve Guide with direct suture repair have been accepted, in abstract form, for presentation at the joint meeting of the American Association for Hand Surgery (AAHS), American Society for Reconstructive Microsurgery (ASRM), and American Society for Peripheral Nerve (ASPN), January 12-18, 2011, Cancun Mexico.
The spiraling use of corn for food and fuel is creating heightened concerns about contamination of this staple crop with deadly aflatoxin.
Savient Pharmaceuticals, Inc. announced that its board of directors, with input from its financial advisors, has determined that a sale of Savient post-approval of KRYSTEXXA by the U.S. Food and Drug Administration (assuming KRYSTEXXA is approved) would be the best way to realize the full commercial potential of KRYSTEXXA on a global basis and would be the optimal outcome for the Company's shareholders and other stakeholders.
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from three studies using the company's breast cancer molecular test.
Delayed transfer to the intensive care unit (ICU) in hospitalized patients significantly increases the risk of dying in the hospital, according to a new study from researchers in Chicago.
› Verified 5 days ago
Entity Name | Duke Health Integrated Practice Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
Integra LifeSciences Holdings Corporation announced today that the results of the multi-center human clinical trial comparing NeuraGen Nerve Guide with direct suture repair have been accepted, in abstract form, for presentation at the joint meeting of the American Association for Hand Surgery (AAHS), American Society for Reconstructive Microsurgery (ASRM), and American Society for Peripheral Nerve (ASPN), January 12-18, 2011, Cancun Mexico.
The spiraling use of corn for food and fuel is creating heightened concerns about contamination of this staple crop with deadly aflatoxin.
Savient Pharmaceuticals, Inc. announced that its board of directors, with input from its financial advisors, has determined that a sale of Savient post-approval of KRYSTEXXA by the U.S. Food and Drug Administration (assuming KRYSTEXXA is approved) would be the best way to realize the full commercial potential of KRYSTEXXA on a global basis and would be the optimal outcome for the Company's shareholders and other stakeholders.
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from three studies using the company's breast cancer molecular test.
Delayed transfer to the intensive care unit (ICU) in hospitalized patients significantly increases the risk of dying in the hospital, according to a new study from researchers in Chicago.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Anupama Betkerur Horne, MD 6104 Fayetteville Rd, Suite 108, Durham, NC 27713-6283 Ph: (919) 572-0050 | Anupama Betkerur Horne, MD 6104 Fayetteville Rd, Suite 108, Durham, NC 27713-6283 Ph: (919) 572-0050 |
News Archive
Integra LifeSciences Holdings Corporation announced today that the results of the multi-center human clinical trial comparing NeuraGen Nerve Guide with direct suture repair have been accepted, in abstract form, for presentation at the joint meeting of the American Association for Hand Surgery (AAHS), American Society for Reconstructive Microsurgery (ASRM), and American Society for Peripheral Nerve (ASPN), January 12-18, 2011, Cancun Mexico.
The spiraling use of corn for food and fuel is creating heightened concerns about contamination of this staple crop with deadly aflatoxin.
Savient Pharmaceuticals, Inc. announced that its board of directors, with input from its financial advisors, has determined that a sale of Savient post-approval of KRYSTEXXA by the U.S. Food and Drug Administration (assuming KRYSTEXXA is approved) would be the best way to realize the full commercial potential of KRYSTEXXA on a global basis and would be the optimal outcome for the Company's shareholders and other stakeholders.
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from three studies using the company's breast cancer molecular test.
Delayed transfer to the intensive care unit (ICU) in hospitalized patients significantly increases the risk of dying in the hospital, according to a new study from researchers in Chicago.
› Verified 5 days ago
Henry Hsien-chun Tseng, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2351 Erwin Rd, Durham, NC 27705 Phone: 919-668-5079 | |
Dr. Zena I-linn Lim, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Duke University Medical Center 3802, 2351 Erwin Road, Durham, NC 27710 Phone: 919-681-3937 Fax: 919-684-6096 | |
Jeremiah Richard Marion Iii, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4102 N Roxboro St, Durham, NC 27704 Phone: 919-595-2106 Fax: 919-595-2190 | |
Brooks Mccuen, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2100 Erwin Rd, Durham, NC 27710 Phone: 919-620-4467 | |
Frankie-lynn Silver, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4101 N Roxboro St, Durham, NC 27704 Phone: 919-684-8111 | |
Dr. Jay Jeffrey Meyer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2301 Erwin Rd, Durham, NC 27705 Phone: 919-684-8111 |